• Email Us: [email protected]
  • Contact Us: +1 718 874 1545
  • Skip to main content
  • Skip to primary sidebar

Medical Market Report

  • Home
  • All Reports
  • About Us
  • Contact Us

UK lobbying regulator probes former PM Cameron for second time this year- FT

October 1, 2021 by David Barret Leave a Comment

October 1, 2021

(Reuters) – Former British prime minister David Cameron is being investigated for the second time this year by the lobbying regulator over whether he should have registered as a consultant lobbyist, the Financial Times reported on Friday.

According to the newspaper, the Office of the Registrar of Consultant Lobbyists is investigating Cameron “in relation to potential unregistered consultant lobbying.”

A formal inquiry began around Aug. 2, the FT said, citing documents.

Cameron has come under pressure in recent months after it was revealed that he lobbied ministers and senior officials repeatedly over access for now-collapsed supply chain finance firm Greensill Capital, to the government’s pandemic funding schemes during a four-month period in 2020.

A parliamentary committee said in July that he had shown a “lack of judgement” in using personal contacts and informal channels to lobby for the firm.

The latest investigation began following reports earlier this year that Cameron had lobbied the then health secretary, Matt Hancock, and the then vaccines minister, Nadhim Zahawi, on behalf of U.S. biotech company Illumina, according to the FT.

The office of the registrar did not immediately respond to a Reuters’ request for comment.

(Reporting by Bhargav Acharya in Bengaluru; Editing by Sandra Maler)

Source Link UK lobbying regulator probes former PM Cameron for second time this year- FT

David Barret
David Barret

Related posts:

  1. Apple M1X MacBook Pro might drop as early as October
  2. White House vows to keep gasoline flowing as U.S. energy firms work to shake off Ida’s toll
  3. Monte dei Paschi prepares to close 50 branches – letter to unions
  4. Billions blown as Macau casino investors fold amid gambling review

Filed Under: News

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Primary Sidebar

  • 170 Years On, Thoreau’s Detailed Diaries Have A Lot To Teach Us About The Seasons
  • Obsidian Blades At The Main Aztec Temple Came From Enemy Territory
  • Humans Glow, And It’s A Light That Probably Goes Out When We Die
  • The Gannon Storm: What NASA Learned From The Biggest Geomagnetic Storm In Over 2 Decades
  • Hypersonic Rocket Plane Successfully Performs Second Test, Soaring Past Mach 5
  • A 13-Year-Old Boy Found A “Lost Sea” Beneath The US. It’s So Vast, It Has Never Been Fully Explored
  • Pollution Related To Space Is Getting Worse As Trump And Musk Target Research And Regulations
  • Invasive, Venomous Ants Lived Under The Radar In The US For 90 Years – Now They’re Spreading
  • Updated Prognosis: The Universe May End 10¹⁰²² Years Sooner Than We Thought
  • When You Get Your Fingers Wet They Wrinkle In The Same Pattern Every Time
  • World-First Footage Shows The Devastating Impact Of Trawling As It’s Happening
  • Blue Galdieria Algae Extract Among 3 Natural Food Dyes Newly Approved By FDA
  • Plastic Chemicals May Delay The Internal Body Clock By 17 Minutes, According To Study
  • Widespread Availability Of RSV Vaccine Linked To Fall In Baby Hospitalizations
  • How Often Should You Wash Your Bedding?
  • What’s The Youngest Language In The World?
  • Look Alert: The Most Active Volcano In the Pacific Northwest Is Probably About To Blow, Maybe
  • Should We Be Using Microwaves?
  • What Is The Largest Deer On Earth?
  • World’s First CRISPR-Edited Spider Produces Glowing Red Silk From Its Spinneret
  • Business
  • Health
  • News
  • Science
  • Technology
  • +1 718 874 1545
  • +91 78878 22626
  • [email protected]
Office Address
Prudour Pvt. Ltd. 420 Lexington Avenue Suite 300 New York City, NY 10170.

Powered by Prudour Network

Copyrights © 2025 · Medical Market Report. All Rights Reserved.

Go to mobile version